vs
帕可Bio（PACB）与PLUMAS BANCORP（PLBC）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是PLUMAS BANCORP的1.6倍（$44.6M vs $28.6M），PLUMAS BANCORP同比增速更快（35.1% vs 13.8%），PLUMAS BANCORP自由现金流更多（$20.3M vs $-19.9M），过去两年PLUMAS BANCORP的营收复合增速更高（20.8% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Plumas Bancorp是一家美国银行控股公司，通过旗下子公司Plumas Bank开展业务，为加利福尼亚州北部及内华达州的个人客户、中小企业和本地社区机构提供存款、各类贷款、财富管理等综合零售及商业银行服务。
PACB vs PLBC — 直观对比
营收规模更大
PACB
是对方的1.6倍
$28.6M
营收增速更快
PLBC
高出21.2%
13.8%
自由现金流更多
PLBC
多$40.2M
$-19.9M
两年增速更快
PLBC
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $28.6M |
| 净利润 | $-40.4M | — |
| 毛利率 | 37.1% | — |
| 营业利润率 | -92.3% | 48.9% |
| 净利率 | -90.4% | — |
| 营收同比 | 13.8% | 35.1% |
| 净利润同比 | -1802.7% | — |
| 每股收益（稀释后） | $-0.11 | $1.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBPLBC
| Q4 25 | $44.6M | $28.6M | ||
| Q3 25 | $38.4M | $27.4M | ||
| Q2 25 | $39.8M | $20.5M | ||
| Q1 25 | $37.2M | $21.8M | ||
| Q4 24 | $39.2M | $21.2M | ||
| Q3 24 | $40.0M | $21.1M | ||
| Q2 24 | $36.0M | $20.6M | ||
| Q1 24 | $38.8M | $19.6M |
净利润PACBPLBC
| Q4 25 | $-40.4M | — | ||
| Q3 25 | $-38.0M | $5.1M | ||
| Q2 25 | $-41.9M | $6.3M | ||
| Q1 25 | $-426.1M | $7.2M | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $-60.7M | $7.8M | ||
| Q2 24 | $-173.3M | $6.8M | ||
| Q1 24 | $-78.2M | $6.3M |
毛利率PACBPLBC
| Q4 25 | 37.1% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 29.1% | — |
营业利润率PACBPLBC
| Q4 25 | -92.3% | 48.9% | ||
| Q3 25 | -101.1% | 25.2% | ||
| Q2 25 | -112.8% | 42.2% | ||
| Q1 25 | -1154.5% | 46.1% | ||
| Q4 24 | -390.1% | 50.3% | ||
| Q3 24 | -160.3% | 50.6% | ||
| Q2 24 | -488.3% | 45.1% | ||
| Q1 24 | -209.6% | 42.8% |
净利率PACBPLBC
| Q4 25 | -90.4% | — | ||
| Q3 25 | -98.9% | 18.8% | ||
| Q2 25 | -105.4% | 30.8% | ||
| Q1 25 | -1146.8% | 33.0% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | -151.9% | 37.1% | ||
| Q2 24 | -481.3% | 32.9% | ||
| Q1 24 | -201.4% | 31.9% |
每股收益（稀释后）PACBPLBC
| Q4 25 | $-0.11 | $1.56 | ||
| Q3 25 | $-0.13 | $0.73 | ||
| Q2 25 | $-0.14 | $1.05 | ||
| Q1 25 | $-1.44 | $1.20 | ||
| Q4 24 | $-0.44 | $1.30 | ||
| Q3 24 | $-0.22 | $1.31 | ||
| Q2 24 | $-0.64 | $1.14 | ||
| Q1 24 | $-0.29 | $1.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $80.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $261.1M |
| 总资产 | $784.1M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBPLBC
| Q4 25 | $279.5M | $80.6M | ||
| Q3 25 | $298.7M | $87.3M | ||
| Q2 25 | $314.7M | $79.3M | ||
| Q1 25 | $343.1M | $87.3M | ||
| Q4 24 | $389.9M | $82.0M | ||
| Q3 24 | $471.1M | $118.0M | ||
| Q2 24 | $509.8M | $109.9M | ||
| Q1 24 | $561.9M | $128.2M |
股东权益PACBPLBC
| Q4 25 | $5.3M | $261.1M | ||
| Q3 25 | $36.1M | $245.9M | ||
| Q2 25 | $61.5M | $193.1M | ||
| Q1 25 | $91.6M | $187.6M | ||
| Q4 24 | $506.6M | $177.9M | ||
| Q3 24 | $453.1M | $181.9M | ||
| Q2 24 | $492.7M | $165.2M | ||
| Q1 24 | $649.0M | $161.5M |
总资产PACBPLBC
| Q4 25 | $784.1M | $2.2B | ||
| Q3 25 | $803.2M | $2.2B | ||
| Q2 25 | $825.5M | $1.6B | ||
| Q1 25 | $860.8M | $1.6B | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.7B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $21.6M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $20.3M |
| 自由现金流率自由现金流/营收 | -44.6% | 70.9% |
| 资本支出强度资本支出/营收 | 1.9% | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $34.4M |
8季度趋势，按日历期对齐
经营现金流PACBPLBC
| Q4 25 | $-19.1M | $21.6M | ||
| Q3 25 | $-18.7M | $5.6M | ||
| Q2 25 | $-29.4M | $2.1M | ||
| Q1 25 | $-44.1M | $7.5M | ||
| Q4 24 | $-30.6M | $30.5M | ||
| Q3 24 | $-45.5M | $8.0M | ||
| Q2 24 | $-54.3M | $5.1M | ||
| Q1 24 | $-75.7M | $9.2M |
自由现金流PACBPLBC
| Q4 25 | $-19.9M | $20.3M | ||
| Q3 25 | $-18.8M | $4.8M | ||
| Q2 25 | $-29.9M | $2.0M | ||
| Q1 25 | $-45.4M | $7.3M | ||
| Q4 24 | $-32.3M | $29.8M | ||
| Q3 24 | $-46.3M | $7.8M | ||
| Q2 24 | $-55.7M | $4.8M | ||
| Q1 24 | $-79.6M | $9.0M |
自由现金流率PACBPLBC
| Q4 25 | -44.6% | 70.9% | ||
| Q3 25 | -48.9% | 17.5% | ||
| Q2 25 | -75.3% | 9.9% | ||
| Q1 25 | -122.3% | 33.7% | ||
| Q4 24 | -82.3% | 141.0% | ||
| Q3 24 | -115.7% | 37.1% | ||
| Q2 24 | -154.8% | 23.5% | ||
| Q1 24 | -205.0% | 45.8% |
资本支出强度PACBPLBC
| Q4 25 | 1.9% | 4.6% | ||
| Q3 25 | 0.2% | 2.9% | ||
| Q2 25 | 1.4% | 0.2% | ||
| Q1 25 | 3.7% | 0.8% | ||
| Q4 24 | 4.1% | 3.2% | ||
| Q3 24 | 2.0% | 0.7% | ||
| Q2 24 | 4.1% | 1.1% | ||
| Q1 24 | 10.0% | 1.0% |
现金转化率PACBPLBC
| Q4 25 | — | — | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | 1.02× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 1.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
PLBC
暂无分部数据
